Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Melacine as adjuvant therapy in melanoma: phase III data reported at SBT meeting

Oct. 30, 2000

Immunotherapy with beta-alethine useful in minimal residual disease

Oct. 30, 2000

Therion and Aventis expand cancer vaccine alliance

Oct. 27, 2000

SRL-172 has positive effects on response rate, survival and quality of life in NSCLC

Oct. 24, 2000

TroVax colorectal cancer vaccine approved for phase I/II

Oct. 23, 2000

Oncophage enters phase II sarcoma study; trial marks drug's seventh cancer indication

Oct. 23, 2000

Status of Dendreon's dendritic cell-based vaccines updated

Oct. 19, 2000

Maxamine inhibits sarcomas in preclinical study

Oct. 19, 2000

Roche begins E.U. launch for Herceptin

Oct. 11, 2000

Two dendritic/cancer cell fusion trials begun by Genzyme Molecular Oncology

Oct. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...